Article citationsMore>>

M. E. Hegi, A.-C. Diserens, S. Godard, et al., “Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in glioblastoma Patients Treated with Temozolomide,” Clinical Cancer Research, Vol. 10, 2004, pp. 1871-1874. http://dx.doi.org/10.1158/ 1078-0432.CCR-03-0384

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top